Evidence map›Paper›PMID 40349018›Full record

Trial reportBMC musculoskeletal disorders2025

Preventive effect of the neurodynamic mobilization technique on delayed onset of muscle soreness: a randomized, single-blinded, placebo-controlled study.

Ugur Sozlu, Selda Basar, Rabia Semsi, Esedullah Akaras, Aylin Sepici Dincel

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05326893 (Preventive Effect of Femoral Nerve Neurodynamic Mobilization Against Maximal Eccentric Exercise-induced Muscle Damage of the Knee Extensors), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05326893 nacompletednot on this map

Preventive Effect of Femoral Nerve Neurodynamic Mobilization Against Maximal Eccentric Exercise-induced Muscle Damage of the Knee Extensors: a Randomized, Single-blinded, Sham-Controlled Study

TypeinterventionalSponsorUğur SözlüRan2020 to 2022Enrolled34ConditionsDelayed Onset Muscle SorenessArmsFemoral nerve neurodynamic mobilization, Femoral nerve placebo neurodynamic mobilization
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ugur SozluDepartment of Physical Therapy and Rehabilitation, Health Science Faculty, Gaziosmanpasa University, Taşlıçiftlik Yerleşkesi, Tokat, 60250, Turkey. ugur.sozlu@gop.edu.tr.ORCID http://orcid.org/0000-0001-5171-161X
Selda BasarDepartment of Physical Therapy and Rehabilitation, Health Science Faculty, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0002-1433-4349
Rabia SemsiDepartment of Medical Biochemistry, Institute of Health Sciences, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8477-5537
Esedullah AkarasDepartment of Physical Therapy and Rehabilitation, Health Science Faculty, Erzurum Technical University, Erzurum, Turkey.ORCID http://orcid.org/0000-0002-0305-4632
Aylin Sepici DincelDepartment of Medical Biochemistry, Gazi University Faculty of Medicine, Ankara, Turkey.ORCID http://orcid.org/0000-0001-5847-0556

Funding

GAZİ University Scientific Research Projects Coordination Unit 47/2020-02
6 · The paper itself

Abstract

backgroundThe neurodynamic mobilization (NM) technique is an intervention designed to restore homeostasis by mobilizing the nervous system and its surrounding structures. NM, through its physiological and biomechanical mechanisms, may play a role in modulating delayed Onset Muscle Soreness (DOMS) symptoms and regulating the emerging inflammatory response. The aim of this study was to determine the preventive effects of the NM technique on DOMS.

methodsThirty-four untrained males were randomized into the NM (n = 17) or placebo NM (n = 17) group. Femoral nerve NM and placebo NM techniques were performed for three weeks in both groups. All the participants subsequently performed 300 maximal isokinetic eccentric contractions of the dominant knee extensors. Markers of muscle damage (creatine kinase, lactate dehydrogenase) and inflammation (IL-6, TNF-α), as well as muscle soreness, pressure pain threshold (PPT) and muscle function, were measured at baseline; immediately before (pre) and after (0 h) the completion of the exercise-induced muscle damage (EIMD) protocol; and at 24, 48, and 72 h.

resultsFollowing the EIMD protocol, muscle soreness peaked at 24 h, while PPT reached its lowest level. The NM group exhibited significantly lower muscle soreness scores (F

conclusionsThree weeks of femoral nerve NM applied to healthy untrained participants had positive effects on the possible negative consequences of DOMS. NM may help alleviate inflammation and muscle damage symptoms and shorten the overall recovery time following DOMS.

trial registration(retrospectively registered): The trial was registered on [03/29/2022] with ClinicalTrials.gov (No: NCT05326893) and conducted according to Consolidated Standards of Reporting Trials (CONSORT) guidelines.

Indexed as

Muscle, SkeletalMyalgiaAdultFemoral NerveHumansMalePain MeasurementPain ThresholdSingle-Blind MethodTime FactorsYoung AdultEccentric exerciseInflammationMuscle damageMuscle sorenessNerve

Identifiers

PMID40349018
PMCPMC12066041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.